
News|Articles|February 7, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 7, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, February 7, 2022, at 3:22 PM, EDT:
42.3% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, February 7, 2022, at 3:22 PM, EDT:
• 64.1% of total US population
• 68.2% of US population aged ≥5 years
• 72.8% of US population aged ≥12 years
• 74.4% of US population aged ≥18 years
• 88.5% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 79.9%
2. Vermont: 79.6%
3. Rhode Island: 79.4%
4. Maine: 77.7%
5. Connecticut: 77%
2. Vermont: 79.6%
3. Rhode Island: 79.4%
4. Maine: 77.7%
5. Connecticut: 77%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, February 7, 2022 at 3:21 PM, EDT, there have been:
• 76 726 776 confirmed cases and
• 904 718 deaths
• 904 718 deaths
The 5 states with the highest total confirmed cases are:
1. California: 8 671 011
2. Texas: 6 433 210
3. Florida: 5 680 958
4. New York: 4 856 199
5. Illinois: 2 971 516
2. Texas: 6 433 210
3. Florida: 5 680 958
4. New York: 4 856 199
5. Illinois: 2 971 516
Deaths: California has the highest number of deaths due to COVID-19 with 81 308 reported fatalities, followed by Texas with 80 750 and Florida with 66 463.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 396 789 120 confirmed cases, 5 747 143 deaths, and 10 070 691 422 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
2
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
3
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
4
Topline Real-World Data Show Fezolinetant Improves VMS, Sleep, and Work Productivity in Women With Confirmed Menopausal VMS
5